Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-14-005433
Filing Date
2014-11-10
Accepted
2014-11-10 17:10:49
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q imuc-10q_20140930.htm 10-Q 683330
2 EX-31.1 imuc-ex311_201409309.htm EX-31.1 16131
3 EX-31.2 imuc-ex312_201409308.htm EX-31.2 16170
4 EX-32.1 imuc-ex321_201409306.htm EX-32.1 7020
5 EX-32.2 imuc-ex322_201409307.htm EX-32.2 7004
  Complete submission text file 0001564590-14-005433.txt   4221681

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT imuc-20140930.xml EX-101.INS 493152
7 XBRL TAXONOMY EXTENSION SCHEMA imuc-20140930.xsd EX-101.SCH 45256
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE imuc-20140930_cal.xml EX-101.CAL 30931
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE imuc-20140930_def.xml EX-101.DEF 106706
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE imuc-20140930_lab.xml EX-101.LAB 309679
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imuc-20140930_pre.xml EX-101.PRE 218439
Mailing Address 23622 CALABASAS ROAD SUITE 300 CALABASAS CA 91302
Business Address 23622 CALABASAS ROAD SUITE 300 CALABASAS CA 91302 818-264-2300
ImmunoCellular Therapeutics, Ltd. (Filer) CIK: 0000822411 (see all company filings)

EIN.: 931301885 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35560 | Film No.: 141209689
SIC: 2834 Pharmaceutical Preparations